The hexanucleotide repeat expansion (HRE) GGGGCC (G 4 C 2 ) in C9orf72 is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recent studies support an HRE RNA gain-of-function mechanism of neurotoxicity, and we previously identified protein interactors for the G 4 C 2 RNA including RanGAP1. A candidate-based genetic screen in Drosophila expressing 30 G 4 C 2 repeats identified RanGAP (Drosophila orthologue of human RanGAP1), a key regulator of nucleocytoplasmic transport, as a potent suppressor of neurodegeneration. Enhancing nuclear import or suppressing nuclear export of proteins also suppresses neurodegeneration. RanGAP physically interacts with HRE RNA and is mislocalized in HRE-expressing flies, neurons from C9orf72 ALS patient-derived induced pluripotent stem cells (iPSC-derived neurons), and in C9orf72 ALS patient brain tissue. Nuclear import is impaired as a result of HRE expression in the fly model and in C9orf72 iPSC-derived neurons, and these deficits are rescued by small molecules and antisense oligonucleotides targeting the HRE G-quadruplexes. Nucleocytoplasmic transport defects may be a fundamental pathway for ALS and FTD that is amenable to pharmacotherapeutic intervention.
The hexanucleotide repeat expansion (HRE) GGGGCC (G 4 C 2 ) in C9orf72 is the most common cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Recent studies support an HRE RNA gain-of-function mechanism of neurotoxicity, and we previously identified protein interactors for the G 4 C 2 RNA including RanGAP1. A candidate-based genetic screen in Drosophila expressing 30 G 4 C 2 repeats identified RanGAP (Drosophila orthologue of human RanGAP1), a key regulator of nucleocytoplasmic transport, as a potent suppressor of neurodegeneration. Enhancing nuclear import or suppressing nuclear export of proteins also suppresses neurodegeneration. RanGAP physically interacts with HRE RNA and is mislocalized in HRE-expressing flies, neurons from C9orf72 ALS patient-derived induced pluripotent stem cells (iPSC-derived neurons), and in C9orf72 ALS patient brain tissue. Nuclear import is impaired as a result of HRE expression in the fly model and in C9orf72 iPSC-derived neurons, and these deficits are rescued by small molecules and antisense oligonucleotides targeting the HRE G-quadruplexes. Nucleocytoplasmic transport defects may be a fundamental pathway for ALS and FTD that is amenable to pharmacotherapeutic intervention.
The G 4 C 2 HRE in the C9orf72 gene is found in as many as 40% of familial ALS and FTD cases, with additional reports in other neurodegenerative diseases [1] [2] [3] . C9orf72 HRE-induced cytotoxicity has been proposed to be caused through loss-and gain-of-function mechanisms that include: (1) transcribed sense GGGGCC exp or antisense (CCCCGG exp ) RNAs that sequester proteins, thus altering their normal function 2 ; or (2) the sense or antisense expanded RNAs are translated via repeat-associated non-AUG translation to form toxic dipeptide repeat proteins (DPRs) [4] [5] [6] [7] . We and others have demonstrated that HRE RNA forms hairpin and G-quadruplex structures that bind and sequester RNA binding proteins (RBPs) 8, 9 .
RanGAP suppresses HRE-mediated toxicity in Drosophila
We previously identified 19 proteins that exhibit high affinity to G 4 C 2 relative to a G:C scrambled RNA, along with ,400 additional proteins that bind with a moderate affinity to G 4 C 2 and/or bind both G 4 C 2 and G:C scrambled RNA 8, 9 . To determine which of these candidate RBPs genetically modifies G 4 C 2 -mediated neurodegeneration, we performed a screen in an established Drosophila model that expresses 30 G 4 C 2 repeats ((G 4 C 2 ) 30 ) in the fly eye 10 (Supplementary Table 1 ). One of the strongest suppressors is a dominant, gain-of-function (GOF) allele of RanGAP, called RanGAP SD (GOF) , that functions similarly to overexpression of wild-type RanGAP (refs [11] [12] [13] . As shown in Fig. 1a , 1-day-old flies expressing (G 4 C 2 ) 30 display subtle ommatidial disorganization defects in the eye that worsen when aged for 15 days (Fig. 1b) . However, flies expressing the same repeats in the heterozygous RanGAP SD (GOF) mutant background or with RanGAP overexpression appear normal (Fig. 1a-c and Extended Data Fig. 1 ), indicating that RanGAP is a suppressor of G 4 C 2 repeat toxicity.
As shown in Fig. 1a , b, wild-type fly eyes have seven photoreceptor neuron (PRN) rhabdomeres per ommatidium. In contrast, the PRNs expressing 30 G 4 C 2 repeats show a loss of integrity and/ or organization of rhabdomeres at day 15 ( Fig. 1a, b, d ), suggesting age-dependent degeneration. These phenotypes are rescued by either heterozygous RanGAP SD (GOF) mutant or RanGAP overexpression. Conversely, knockdown of RanGAP by RNA interference (RNAi) significantly enhances the PRN defects ( Fig. 1d and Extended Data Fig. 1a) . Moreover, RanGAP knockdown-mediated enhancement of (G 4 C 2 ) 30 -mediated degeneration worsens with age, with an almost complete loss of rhabdomeres in aged flies which is not due to alterations in G 4 C 2 mRNA level (Extended Data Fig. 1b ). These data indicate that RanGAP is a potent suppressor of G 4 C 2 -mediated neurodegeneration in the Drosophila eye.
To determine whether RanGAP also suppresses G 4 C 2 -mediated toxicity in Drosophila motor neurons, we next analysed the effect of RanGAP overexpression on the locomotor function of adult flies. Neuronal expression of (G 4 C 2 ) 30 throughout adulthood causes flight defects in 15-day-old flies that are rescued with simultaneous overexpression of RanGAP (Extended Data Fig. 1c, d) . Interestingly, when expressed in motor neurons throughout larval development using OK371-GAL4, (G 4 C 2 ) 30 causes severe neuromuscular junction (NMJ) defects including an ,50% reduction in active zone number and impaired evoked neurotransmitter release not rescued by RanGAP overexpression (Extended Data  Fig. 2 ). Together, these data suggest that RanGAP suppresses G 4 C 2 -mediated neurodegeneration during adulthood, whereas (G 4 C 2 ) 30 expression during development causes neurotoxicity that is independent of RanGAP.
Nucleocytoplasmic transport modulates G 4 C 2 toxicity
RanGAP functions in the cytoplasm to stimulate Ran GTPase (hereafter referred to as Ran) to hydrolyse GTP to GDP, a process required for efficient nucleocytoplasmic transport 12, 14, 15 . Proteins larger than 40 kDa require active transport to cross the nuclear pore complex (NPC), in which their nuclear localization sequence (NLS) and/or nuclear export signal (NES) are recognized by carrier protein importins and/or exportins, respectively [16] [17] [18] . In the nucleus, exportins bind RanNGTP and cargo proteins for export. Nuclear Ran guanine nucleotide exchange factor (RanGEF) converts RanNGDP back to RanNGTP 19 . As shown in Fig. 1c, d and Extended Data Fig. 1a , b, overexpression of RanGEF enhances G 4 C 2 -repeat-mediated degeneration, resulting in large necrotic patches and severe rhabdomere degeneration. In contrast, knockdown of RanGEF rescues both of these phenotypes. These data suggest that RanGEF has an opposite role when compared with RanGAP in G 4 C 2 -mediated neurodegeneration, consistent with their opposing biochemical functions. Overexpression of importin-a or knockdown of exportin rescues these phenotypes. Thus, genetically enhancing nuclear import or inhibiting export of NLS/NES-containing proteins suppresses G 4 C 2 -mediated neurodegeneration.
Expression of arginine-containing DPRs in Drosophila causes severe toxicity and poly-glycine-arginine (GR) DPRs are detected in flies expressing 36 G 4 C 2 repeats under the control of heat-shock-inducible GAL4 (hs-GAL4) 7 . Although we are also able to detect polyGR DPRs in hs-GAL4, UAS-(G 4 C 2 ) 30 flies when heat shocked, we are not able to detect polyGR or polyGP DPRs when (G 4 C 2 ) 30 is expressed in the eye with GMR-GAL4 at the time of PRN degeneration or in adult neurons with elavGS (Extended Data Fig. 3a, b) . Nonetheless, we cannot exclude the possibility that DPRs are expressed at undetectable levels and contribute to degeneration in the eye.
G 4 C 2 repeats bind RanGAP and cause NPC pathology
To determine the relative affinity of RanGAP for G 4 C 2 RNA, we performed an electrophoretic gel mobility shift assay (EMSA) with (G 4 C 2 ) 10 RNA and recombinant human RanGAP1 (Extended Data  Fig. 4a) . The sense (G 4 C 2 ) 10 RNA G-quadruplex shows a concentration-and length-dependent shift of free RNA to a lower mobility RNA-RanGAP1 complex with increasing concentrations of RanGAP1 ( Fig. 2a and Extended Data Fig. 4b-d) . Additionally, RanGAP1 demonstrates a higher binding affinity to the sense strand G-quadruplex compared to hairpins (Extended Data Fig.  4b-d) , and very little interaction was observed between RanGAP1 and (CUG) 20 . Furthermore, the RanGAP1-(G 4 C 2 ) 10 complex is resistant to antisense oligonucleotides against the G 4 C 2 repeat and nonspecific RNA competitor even at 1,000-fold RNA molar excess (Extended Data Fig. 4e ). These in vitro results indicate that RanGAP1 preferentially binds the sense RNA G-quadruplex from the C9orf72 HRE. To confirm that RanGAP interacts with G 4 C 2 RNA in cells, we expressed carboxy-terminal haemagglutinin (HA)-tagged Drosophila RanGAP protein in S2 cells and performed RNA pull down. As shown in Fig. 2b , western blot analysis demonstrates that the full-length and C-terminal domain of RanGAP physically interact with G 4 C 2 -repeat RNA in Drosophila cells. Both endogenous and transfected RanGAP-HA uniformly surrounds the nuclei of control cells ( Fig. 2c and Extended Data Fig. 5a, b) . In contrast, expression of (G 4 C 2 ) 30 leads to formation of large RanGAP perinuclear puncta, which is not due to induction of apoptosis (Extended Data Fig. 5a ).
In parallel with studies in Drosophila, we investigated RanGAP1 in iPSC-derived neurons (hereafter referred to as iPSC neurons) derived from multiple C9orf72 ALS (C9-ALS) patients (Extended Data Fig. 6 and Supplementary Tables 3 Table 3 and Extended Data Fig. 6b, c) . Consistent with our observations in S2 cells, iPSC neurons from C9-ALS patients variably exhibit RanGAP1 puncta (Extended Data Fig. 5c ), and RanGAP1 can co-localize with G 4 C 2 RNA (Fig. 2d) . Notably, to determine whether RanGAP1 mislocalization occurs in human disease, we analysed brain tissue of C9-ALS patients. Cells in C9-ALS motor cortex commonly exhibit mislocalized, discontinuous and large punctate RanGAP1 signals compared to smooth perinuclear staining observed in controls ( Table 2 ). Similar pathology was not readily observed in C9-ALS cerebellar cortex (Extended Data Fig. 7e ). Perinuclear cytoplasmic RanGAP1 puncta occasionally co-localize with ubiquitin (Extended Data Fig. 5e ). We next asked whether RanGAP1 puncta contain other protein components of the NPC, and therefore stained for nucleoporin 205 (Nup205), an extremely long-lived NPC scaffold protein 20, 21 . We found that RanGAP1 and Nup205 co-localize and are predominantly perinuclear in control iPSC neurons and brain tissue (Fig. 2f) . Interestingly, Nup205 co-localizes with some RanGAP1 aggregates in C9-ALS iPSC neurons (Extended Data Fig. 5d ). Consistent with this observation, Nup205 and Nup107 exhibit similar motor cortex pathology as RanGAP1 in multiple C9-ALS patients (Fig. 2f, Extended Data Fig. 7f and Supplementary Table 2 ). These data suggest that RanGAP1 and additional components of the NPC are disrupted in C9-ALS patients.
The Ran gradient is disrupted by the C9orf72 HRE We then tested whether sequestration of RanGAP by the G 4 C 2 RNA leads to its loss of function. Most Ran protein is imported into the nucleus, a process that requires its binding to GDP, but not GTP [22] [23] [24] . Hence, defects in RanGAP1 activity might affect the nuclearcytoplasmic (N/C) distribution of Ran. Indeed, we observed a significant reduction in the N/C ratio of Ran in S2 cells expressing (G 4 C 2 ) 30 ( Fig. 3a) , suggesting that RanGAP function is impaired.
Next, we quantified nuclear and cytoplasmic Ran in C9-ALS iPSC neurons via immunofluorescence (Fig. 3b-d and Extended Data Fig. 8b, c) . We observed a significant reduction in the N/C ratio of endogenous Ran in the C9-ALS lines tested in mature MAP2
1 iPSC neurons at 50-70 days in vitro (DIV) (Fig. 3c, d ). Ran gradient abnormalities were also detected in mature ChAT + neurons within the same cultures ( Fig. 3e and Extended Data Fig. 8a ). Overexpression of a functional Ran-GFP fusion protein in C9-ALS iPSC neurons also showed reduced N/C Ran gradients in C9-ALS iPSC neurons (Extended Data Fig. 8b, c) .
RanGAP1-GFP overexpression in C9-ALS iPSC neurons rescued the disrupted N/C Ran gradient to control levels (Extended Data Fig.  8d ), demonstrating that altered RanGAP1 function contributes to the disrupted N/C Ran ratio. The disrupted Ran gradient is not due to apoptosis, since treatment of control iPSC neurons with tunicamycin does not alter the N/C Ran ratio despite elevating activated caspase 3 levels (Extended Data Fig. 8e ), and RanGAP1 and Ran mislocalization were not observed in iPSC astrocytes derived from C9-ALS patients (Extended Data Figs 6d and 8f-i). Taken together, our fly and human iPSC data indicate that the G 4 C 2 HRE impairs neuronal RanGAP1 function, resulting in higher levels of cytoplasmic Ran protein.
The C9orf72 HRE inhibits import of nuclear proteins
To determine whether the HRE significantly impairs nuclear import, we overexpressed a GFP protein tagged with both a classical NLS and a NES (NLS-NES-GFP) 12 in the Drosophila salivary gland where the cytoplasm and nucleus are large and distinct. NLS-NES-GFP is localized to both nuclei and cytoplasm of wild-type salivary gland cells (Fig. 4a) . However, in cells expressing (G 4 C 2 ) 30 , the N/C ratio of NLS-NES-GFP is severely reduced (Fig. 4a and Extended Data Fig. 9a ), suggesting that nuclear import is inhibited and/or that nuclear export is enhanced.
Next, we expressed a GFP protein tagged with an NLS and a mutated NES, which severely impairs its export activity (DNES) 12 . In control cells, NLS-DNES-GFP localizes primarily to the nucleus (Fig. 4a) , whereas in cells expressing (G 4 C 2 ) 30 it localizes predominantly to the cytoplasm ( Fig. 4a and Extended Data Fig. 9a ), supporting an impairment of nuclear import in these cells. Using immunoblot analysis, we confirmed that the levels of GFP protein are similar in control and (G 4 C 2 ) 30 -expressing salivary glands (Extended Data Fig.  9b ). We also detected cytoplasmic mislocalization of NLS-NES-GFP and NLS-DNES-GFP in glutamatergic neurons of the ventral nerve cord in (G 4 C 2 ) 30 -expressing flies (Extended Data Fig. 9d) , indicating that the G 4 C 2 HRE also affects nucleocytoplasmic transport in Drosophila motor neurons. Therefore, expression of the G 4 C 2 HRE decreases nuclear import in Drosophila cells in vivo. Supplementary Table 4 ) (**P , 0.01, ****P , 0.0001). Error bars indicate s.e.m.
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We next investigated the effects of nuclear import deficits on candidate nuclear NLS-or NES-containing proteins. TDP-43 (TBPH in Drosophila), a predominantly nuclear protein, contains both a classical NLS and NES, and it is depleted from the nucleus of some CNS neurons and glia in most ALS patients and ,45% of FTD patients 25 . Therefore, we hypothesize that its nuclear localization will be affected if nuclear import is disrupted. Indeed, loss of nuclear Ran correlates with depletion of nuclear TDP-43 in an FTD mouse model 26 . As shown in Fig. 4a and Extended Data Fig. 9c , the N/C ratio of endogenous TBPH is significantly reduced in (G 4 C 2 ) 30 -expressing salivary gland cells.
To validate our observations in human neurons, we investigated nucleocytoplasmic transport in iPSC neurons by expressing a tdTomato reporter with a classical NLS and NES and performing fluorescence recovery after photobleaching (FRAP) of neuronal nuclei 27 . We observed reduced nuclear recovery of NLS-tdTomato-NES in C9-ALS iPSC neurons when compared with control lines (Fig. 4b, c) . This defect was associated with disruption of TDP-43 localization, as C9-ALS iPSC neurons exhibit variable, but significantly reduced, N/C ratios for TDP-43 ( Fig. 4d-f) . N/C ratios of Ran and TDP-43 correlate in control and C9-ALS iPSC neurons (Fig. 4g) , consistent with previous findings that the nuclear import of TDP-43 is Ran dependent 28 . These data indicate that the C9-ALS HRE leads to impaired nuclear import of proteins that contain a classical NLS.
Rescue of HRE-mediated neurodegeneration
To determine whether antisense oligonucleotides targeting the C9orf72 RNA rescue the disrupted N/C Ran ratio observed in C9-ALS iPSC neurons, we treated these cells with C9 sense or scrambled antisense oligonucleotides used previously 8, 29, 30 . The sense strand antisense oligonucleotide treatment reduced RNA foci in C9-ALS iPSC neurons (Extended Data Fig. 8j ) and fully rescued the disrupted N/C Ran gradient (Fig. 5a) , suggesting that the nucleocytoplasmic transport deficits are due to C9orf72 sense-strand toxicity. Notably, when C9-ALS iPSC neurons were treated with these antisense oligonucleotides, both the N/C Ran and TDP-43 gradients were increased (Extended Data Fig. 8k ). The antisense oligonucleotide also suppressed nuclear import defects caused by G 4 C 2 repeats in vivo. Drosophila larvae co-expressing (G 4 C 2 ) 30 and NLS-DNES-GFP were raised on food supplemented with an antisense oligonucleotide throughout larval stages, mitigating nuclear mislocalization of NLS-DNES-GFP in salivary glands (Fig. 5b) .
RanGAP1 binds the G 4 C 2 RNA G-quadruplex in vitro (Fig. 2a) . Therefore, we then tested whether this interaction can be perturbed by a porphyrin compound, TMPyP4, that destabilizes RNA G-quadruplex tertiary structures 31 . TMPyP4 reduces the affinity of RanGAP1 for the (G 4 C 2 ) 10 G-quadruplex in a dose-dependent manner (Fig. 5c ). TMPyP4 also rescues nuclear import defects in the fly model in a dose-dependent manner (Fig. 5d) . Thus, inhibition of the G 4 C 2 G-quadruplex structure significantly suppresses HRE-mediated nuclear import deficits. Interestingly, these phenotypes are also suppressed using an exportin 1 inhibitor, KPT-276 (Fig. 5e ) 32 , suggesting that inhibiting nuclear export may compensate for disrupted import. Notably, antisense oligonucleotide, KPT-276, or TMPyP4 treatments all significantly suppress G 4 C 2 -mediated neurodegeneration in the eye (Fig. 5f ). Hence, our data suggest that modulation of nucleocytoplasmic transport presents a potential therapeutic strategy for neurodegenerative diseases characterized by the C9orf72 HRE.
Discussion
Our data demonstrate that the G 4 C 2 repeat expansion disrupts nucleocytoplasmic transport in a fly model and in human cells (Extended Data Fig. 10 ). While our data suggest that RanGAP is a key target of the G 4 C 2 repeat expansion, other members of the NPC may also interact directly or indirectly with G 4 C 2 . Several human genetic studies have implicated nuclear transport deficits as the cause of a rare fetal motor neuron disease and infrequent cases of ALS, including studies on the role of the nucleoporin GLE1 implicated in mRNA export 33, 34 . In addition, irregularities of the nuclear membrane and distribution of nuclear pore proteins were recently noted in sporadic ALS tissue 35 . An accompanying paper (ref. 36) independently identified additional components of the NPC and nucleocytoplasmic trafficking pathways as dominant modifiers of G 4 C 2 HRE toxicity in another C9-ALS fly model. Importantly, the observed NPC and nucleocytoplasmic trafficking defects in both iPS-cellderived neurons and motor neurons in our study are relevant to both ALS and FTD. Taken together, these studies suggest that products of the C9orf72 HRE disrupt nucleocytoplasmic transport at the NPC and are a fundamental mechanism for inducing cellular injury in ALS and FTD. These defects may account for the nuclear depletion and cytoplasmic accumulation of TDP-43 widely seen in C9-ALS and FTD.
Although our data only demonstrate a role for disruption of nuclear import in C9-ALS pathogenesis, the robust nuclear pore pathology that we detect suggests that both nuclear import and export may be affected. It is enticing to speculate that NPC dysfunction leads to agerelated neurodegeneration, since many of the NPC components, including Nup205, are extremely long-lived 20 , and NPC integrity is lost during normal ageing 37 .
The sense strand appears to be the cause of the described nucleocytoplasmic trafficking deficits in our human and fly model systems, as small molecules targeting the sense RNA suppress the nuclear import phenotypes, and neurodegeneration is caused by expression of G 4 C 2 repeat RNA in C9orf72 iPSC neurons or Drosophila. While we cannot exclude DPRs as a contributor to nucleocytoplasmic trafficking defects, our data in multiple model systems are most consistent with an RNAmediated mechanism. Future studies will be required to determine the contribution of RanGAP disruption in C9-ALS pathogenesis compared with other pathogenic mechanisms implicated in C9-ALS such as nucleolar stress, which could act independently or in conjunction with nucleocytoplasmic transport disruption 9 .
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METHODS
For all Drosophila experiments, the experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment.
Investigators were blinded for analysis of all iPSC neuron experiments investigating the N/C Ran ratio, N/C TDP-43 ratio, and FRAP live imaging. Drosophila genetics. To identify genetic modifiers of G 4 C 2 HRE, the candidatebased screen was performed as follows: if a candidate RBP 8 is conserved between human and Drosophila, we obtained the RNAi lines against the Drosophila homologue(s) from the TRiP collection (Supplementary Table 1) 38 . In addition, if the RBP consistently exhibited high affinity to G 4 C 2 RNA, we also obtained published mutant alleles of their homologues. RanGAP SD (GOF) refers to the RanGAP SD 'segregation distortion' gain-of-function allele [11] [12] [13] . We recombined GMR-GAL4 and UAS-(G 4 C 2 ) 30 (ref. 10 ) and crossed the balanced line, GMR-GAL4, UAS-(G 4 C 2 ) 30 /CyO, twiGFP, to RNAi or mutant lines. We selected progeny that either co-expressed both the repeats and the RNAi (GMR-GAL4, UAS-(G 4 C 2 ) 30 /1; UAS-RNAi/1, where the UAS-RNAi can be on any chromosome), or expressed the repeats in a heterozygous mutant background (GMR-GAL4, UAS-(G 4 C 2 ) 30 /1; mut/1, where mut can be on any chromosome). We aged flies for 15 days and compared the morphology of their eyes with 15-day-old control flies expressing only the repeats. We used a modification index ranging from 24 to 4 to describe the relative severity of the morphological defects (Supplementary Table 1 ), where 0 is the repeat-expressing control. A positive number indicates enhancement of the phenotype, whereas a negative number indicates rescue. A number of 4 was given if the flies have no eyes, whereas a number of 24 was given if eyes appear indistinguishable from that of the wild-type control. If the flies fail to eclose, we indicate the phenotype as 'lethal'.
In our genetic interaction analyses, we used a previously described method 39 to quantify disruption in the external morphology of the eye, that is, 'degeneration score'. Briefly, points were added if there was complete loss of interommatidial bristles, necrotic patches, retinal collapse, loss of ommatidial structure, and/or depigmentation of the eye.
For the subcellular localization of GFP, OK371-GAL4; UAS-(G 4 C 2 ) 30 /TM6b, Tb, tub::GAL80 was crossed to UAS-NLS-NES(P12)/TM6b, Tb (III) and non-Tb offspring were selected for analysis (NES(P12) is referred to as DNES). OK371-GAL4/UAS-NLS-NES-GFP flies were used as a negative control. We did not observe any GFP signals in the third instar salivary glands of OK371-GAL4; UAS-(G 4 C 2 ) 30 /1 animals. All other fly stocks are from Bloomington Drosophila Stock Center, except for the UAS-RanGAP lines generated in this study.
To induce G 4 C 2 RNA expression using elavGS (ref. 40) , flies were raised at 29 uC on regular food supplemented with 300 mM RU486. Flies were transferred to freshly made food every 2-3 days. Quantitative RT-PCR. For each genotype, mRNA was collected from 30 fly heads using the TRIzol reagent (Life Technologies) following the manufacturer's protocol. Reverse transcription was performed using SuperScript III First-Strand synthesis kit (Life Technologies) following the manufacturer's protocol. Quantitative PCR was performed using SYBR Green PCR system (Applied Biosystem) on a 7900 HT fast Real-Time PCR system (Applied Biosystem). The following primers were used. For actin: forward 59-GCGCGGTTACTCTTTCACCA-39, reverse 59-ATGTCACGG ACGATTTCACG-39. For G 4 C 2 repeats: forward 59-GGGATCTAGCCACCATG GAG-39, reverse 59-TACCGTCGACTGCAGAGATTC-39.
The primers for G 4 C 2 repeats were designed to amplify a 39 region immediately after the repeats in the UAS construct. Flight assay. The flight assay was performed as described 41 . Briefly, individual 15-day-old female flies were dropped into a graduated cylinder through a hole in its lid. The cylinder was graduated into 12 zones of 25 mm each (top: 0; bottom: 12). The landing height was noted as the zone number in which the fly landed. Electrophysiological recording. For fly third instar larvae, neuromuscular (NMJ) recordings were performed from muscle 6 in segments A3 and A4 at room temperature in 1.5 mM Ca 21 containing HL3 as described 42 . For iPS cells, whole-cell patch-clamp recordings were performed to assess the functionality of iPSC neurons. Neurons were perfused in HEPES-buffered extracellular solution (143 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 10 mM HEPES, 10 mM glucose, pH 7.2, 300-310 mOsm) in the presence of 1 mM TTX and 20 mM bicuculline. Whole-cell recording pipettes (4) (5) (6) (7) (8) were filled with a Cs-based internal solution (115 mM Cs-MeSO 4 , 0.4 mM EGTA, 5 mM TEA-Cl, 2.8 mM NaCl, 20 mM HEPES, 3 mM MgATP, 0.5 mM Na2GTP, pH 7.2, 290-300 mOsm) for voltage-clamp mEPSC recordings or with a K 1 -based internal solution (2.7 mM KCl, 120 mM KMeSO 4 , 9mMHEPES, 0.18 mM EGTA, 4 mM MgATP, 0.3 mM Na2GTP, 20 mM phosphocreatine(Na), pH 7.3, 295 mOsm) for current-clamp experiments. Cells were held at 270 mV holding potential and recording was performed at room temperature. Signals were measured with MultiClamp 700B amplifier and digitized using a Digidata 1440A analogue-to-digital board (Molecular Devices). Data acquisition was performed with pClamp 10.3 software and digitized at 5 or 20 kHz. iPSC generation and differentiation to neurons. Patient fibroblasts were collected at Johns Hopkins Hospital with patient's consent (IRB protocol: NA_00021979) as described previously 8 . iPSC lines were created and initially characterized with an NIH-sponsored commercial agreement with iPierian (USA) using the 4 vector method. Sox2, Oct4, Klf4 and c-Myc encoding vectors were transduced into human fibroblasts using retrovirus delivery. Selected colonies were evaluated for expression of multiple pluripotent markers by quantitative PCR (qPCR) and/or immunocytochemistry. In vitro pluripotency was further determined by three germ layer differentiation via embryoid body formation. iPSCs were maintained in mTeSR1 (StemCell Technology) and passed once a week using dispase (StemCell Technology) following the manufacturer's instructions. Partially differentiated colonies were removed manually before differentiation analyses. The iPSCs were differentiated to neuroprogenitor cells, neurons and motor neurons via embryoid body (EB) formation by following the methods described previously (Supplementary Table 3) 43 . At day 32 of differentiation, iPSC neurons were treated with 20 mM Ara-C (Sigma) for 48 h to remove iPS glial progenitor cells and enrich for iPSC neurons. iPSC neuronal differentiation was confirmed by class-III Tubulin (Tuj1) immunostaining (Chemicon AB9354, 1:1,000), and cultures used for subsequent experiments were plated onto a confluent layer of mouse astrocytes, and analyses were performed at 55-69 DIV. Differentiation was assessed by immunofluorescence for the presence of MAP2-positive cells (SySy 188 004; 1:1,000) and neuronal morphology. Approximately 85-90% of cells were VGlut 1 1 (SySy 135 303; 1:500), ,10% were VGat 2 (SySy 131 002; 1:500), ,40% of neuronal cultures were Islet-1 1 (DSHB, 40.3A4; 1:50), ,90% were ChAT 1 (Millipore, AB144P, 1:300). All lines were analysed at 50-70 DIV. Molecular cloning. RanGAP full-length and/or truncated cDNAs were retrieved from cDNA clone LD16356 44 and subcloned into pUASt-attB vector 45 using BglII and NotI sites. An HA tag was added at the C terminus. The NLS-tdTomato-NES construct was provided by the Hetzer lab (Salk Institute) and was subcloned into PrecisionShuttle Lenti vector with C-terminal Myc-DDk tag (OriGen, catalogue number PS100064) using MluI and XhoI cloning sites. Transgenic flies. Transgenic flies containing RanGAP cDNA constructs were generated by injecting the plasmid into y w;; PBac{yellow[1]-attP-3B}VK00033 (chromosome III) embryos (BestGene, Inc.) 46 . Collection of human autopsied tissue. Human autopsied tissue used for these data are described in detail in Supplementary Table 2 . The use of human tissue and associated decedents' demographic information was approved by the Johns Hopkins University Institutional Review Board and ethics committee (HIPAA Form 5 exemption, Application 11-02-10-01RD) and from the Ravitz Laboratory (UCSD) through the Target ALS Consortium. Antisense oligonucleotide treatment for iPSC neuronal cultures. Modified 29-methoxyethyl (MOE)/DNA antisense oligonucleotides were generated by Isis Pharmaceuticals. For antisense oligonucleotide treatment, antisense oligonucleotides were incubated in neural differentiation media (NDM) at 3 mM then added to the iPSC neuronal cultures and replenished every 3 days for a total of 10 DIV with antisense oligonucleotides. Sequence for the antisense oligonucleotide-577061 targeted upstream of the G 4 C 2 repeat is 'TACAGGCTGCGGTTGTTT CC' and the scrambled non-targeting control antisense oligonucleotide-141923 sequence is 'CCTTCCCTGAAGGTTCCTCC'. RNA fluorescent in situ hybridization (FISH) and immunofluorescence. RNA-FISH of iPSC neurons was performed as previously described 8 . Briefly, 59 digoxigenin (DIG)-labelled locked nucleic acid FISH probes used were generated by Exiqon and targeted the GGGGCC repeat (CCCCGG 2.5 ) (batch 611635) or a non-targeting scrambled probe (300514-04) as a control. Cell cultures were fixed in buffered 4% PFA, equilibrated in 13 SSC with 40% formamide, incubated at 37 uC for 10 min, then incubated with preheated probes (90-95 uC) at 75 uC for 35 min in 50% formamide and hybridization buffer containing 20 nM of probe. Following hybridization, cells were washed 23 with 50% formamide at 55 uC for 15 min each and then washed with 23 SSC 5 times for 5 min each.
Cells processed for RNA-FISH and protein immunofluorescence for RanGAP1 were treated once with Tris-glycine, and processed for standard protein immunofluorescence. Blocking buffer and immunofluorescence buffer consisted of 10% and 5% protease and heat-shocked BSA fraction V (Roche) in RNase free 13 Tris buffered saline, respectively. To detect the DIG-labelled probe, an unconjugated mouse anti-DIG antibody (Jackson Immunoresearch 200-002-156; 1:400) and RanGAP1 antibody (Santa Cruz sc-25630; 1:500) was used followed by the appropriate secondary antibody (Jackson). Cells then underwent a series of 5 min washes with immunofluorescence buffer, Tris buffered saline, Tris-glycine, PBS with MgCl 2 and PBS, respectively. Cells were mounted onto slides with ProLong Antifade Gold mounting media with DAPI (Invitrogen).
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Drosophila cell culture. S2 cells were cultured in Schneider's media supplemented with fetal bovine serum and antibiotics at 25 uC. The transfections were performed using Lipofectamine LTX (Life Technologies) following the manufacturer's instructions. G 4 C 2 repeat mRNA was transcribed using the UAS/GAL4 system 47 , driven by Act-GAL4. For immunofluorescent staining, cells were fixed 48 h after transfection. For actinomycin treatment to induce apoptosis, cells were treated with 0.7 mM actinomycin D for 20 h. Immunofluorescence, phalloidin staining and immunohistochemistry. For immunofluorescence staining in Drosophila, tissues or S2 cells were fixed in 3.7% formaldehyde for 30 min, followed by incubation in PBX solution (PBS with 0.4% Triton X-100) for 1 h. The tissues or cells were then incubated with primary antibodies and 10% normal goat serum (NGS) in PBX for 16 h at 4 uC. Primary antibodies were used at the following concentrations: mouse anti-Brp (DSHB), 1:100; mouse anti-GFP (Life technologies), 1:200; rat anti-HA (Roche), 1:200; rabbit anti-RanGAP (a gift from C. Staber, Stowers Institute), 1:500; mouse anti-Ran (BD Biosciences), 1:200; rabbit anti-TBPH (a gift from F. Hirth, King's College) 48 , 1:200; and rabbit anti-antisense oligonucleotide (provided by F. Rigo, Isis Pharmaceuticals), 1:1,000. Next, samples were washed in PBX for 8 h at room temperature (RT) and then incubated with secondary antibodies conjugated to Alexa Fluor 546 or 488 (Life Technologies) in PBX110% NGS at 4 uC for 16 h. The secondary antibodies were used at a dilution of 1:200. After that, samples are washed in PBX for 6 h and then stained with 1 mM TO-PRO3 (Life Technologies) for 10 min at RT.
For phalloidin staining, fixed eyes were incubated in PBX with Alexa Fluor 488 Phalloidin (Life Technologies) at 1:20 for 16 h at 4 uC. The eyes were then washed in PBX for 1 h at RT before mounting.
For immunostaining of iPSC neurons, cells were grown on 12 mm coverglass on top of a confluent monolayer of mouse astrocytes fixed in 4% PFA, permeabilized in 0.3% Triton X-100/13 PBS and blocked in 10% normal donkey serum before incubation with primary antibody. For human autopsied tissue, paraffin motor cortex tissue (see Supplementary Table 2 ) was washed in xylene (33 5 min), then a series of 100% ethanol (23 5 min), 90% ethanol (13 5 min), 70% ethanol (13 5 min) and washed with water (23 5 min). Antigen retrieval was performed using a steamer for 1 h in epitope retrieval solution (IHC world) then washed with water (33 5 min). Slides were treated with 50:50 methanol: acetone solution for 10 min and then washed with 13 PBS (23 5 min). Permeabilization was performed with 0.4% Triton X-100/13 PBS (8 min) and were then washed (13 PBS) and blocked overnight in 10% normal goat serum/13 PBS. Primary antibodies were added and incubated for 24 h at 4 uC (RanGAP1 Santa Cruz, sc-25630, 1:50; Nup205 Novus NBP1-91247, 1:50). For DAB staining, tissues were incubated with biotinylated goat-anti-rabbit secondary antibody (Jackson Immunoresearch) at 1:200 for 1 h at room temperature and then processed using the Vectastain Kit (Vector Labs) following the manufacturer's instruction. Cells and tissue were then washed 5 times for 5 min with 13 PBS and then 1 time with water and mounted using ProLong Antifade Gold with DAPI. Microscopy and image analysis. For fly experiments, samples were mounted in Vectashield (Vector Laboratories) and analysed under a confocal microscope (model LSM510; Carl Zeiss) with its accompanying software using Plan Apochromat 633, NA 1.4 objectives (Carl Zeiss) at RT. Images were captured by AxioCam HRc camera (Carl Zeiss) or Hamamatsu Flash 4.0 (Hamamatsu). Images are processed using ImageJ (National Institutes of Health). Deconvolution was performed using the Tikhonov-Miller method.
For iPSC experiments, Z-stack images taken on a Zeiss Axioimager with the Apotome tool or a Zeiss LSM700 (NIH Grant S10 OD016374) laser scanning confocal microscope, all images were taken at matched exposure times or laser settings and normalized within their respective experiment. All comparative images were processed using identical settings.
Nuclear/cytoplasmic ratios were quantified using Z-stacks of iPSC neuronal cultures on the Zeiss Axioimager with the Apotome tool. Full Z-stacks were taken at 0.5 mm intervals and the individual planes were then projected into maximum intensity images removing any lower layers that contain the astrocyte monolayer. The nuclear region was determined using either DAPI or Lamin-B (Santa Cruz sc-6217; 1:300) and the cytoplasmic fraction was determined using MAP2 (SySy 188 004; 1:1000). Ran was visualized using a Ran antibody (BD Biosciences 610341; 1:100) or Ran-GFP (OriGene, RC204223L2). Images were quantified using ImageJ (NIH) and the mean pixel intensity per mm 2 was determined to generate the nuclear/cytoplasmic ratios. All iPSC lines were imaged at 50-70 DIV. FRAP analysis. FRAP analysis was performed as previously described 27 with modifications. Ctrl or C9-ALS iPSC neurons were transduced with a lenti-CMV-NLS-tdTomato-NES construct provided by the Hetzer Laboratory (Salk Institute) at 51 DIV. Cells expressing the tdTomato reporter were then imaged on an LSM700 and processed with Zen software (Carl Zeiss). Three images were taken of the tdTomato-expressing iPSC neurons at which point the nucleus was bleached for 30 iterations of 40-60% laser power and recovery was monitored every 3 s for 150 intervals. Recovery was normalized to the average of the prebleached signals. To account for global bleaching, all post-bleach signals were also normalized by a 'bleach factor' at each time point, which was determined by the per cent of signal lost post-bleach in an unbleached transfected cell. Purification of recombinant RanGAP1 from Escherichia coli. RanGAP1 cDNA was provided by S. Blackshaw. The cDNA was cloned into a SspI-digested linear pET28a vector in frame with a 63His-EGFP N-terminal fusion using Gibson assembly cloning strategies (NEB). A 50 ml LB starter culture of RanGAP1 with ampicillin/chloramphenicol was grown overnight at 37 uC. Then 25 ml of the overnight starter culture was added to 1 l of pre-warmed LB with ampicillin/chloramphenicol and incubated at 37 uC until OD 600 5 0.7-1 absorbance (abs). The temperature was then dropped down to 16 uC and protein expression was induced with 1 mM IPTG and induced overnight at 16 uC. The cell culture was then centrifuged at 4,000g for 20 min. The cell pellet was resuspended in 50 ml of resuspension buffer (20 mM HEPES, 200 mM NaCl, 10 mM imidazole, 1 mM TCEP, pH 7.4) containing EDTA-free protease inhibitor (Roche). Cells were lysed via French press while on ice, and were then centrifuged at 30,000g for 30 min. The lysed cell supernatant was collected and filtered through a 0.45 mm membrane (Millex-HV Filter Unit) and then loaded onto an Ä KTApurifier 10 superloop at 4 uC. A 5 ml HisTrap HP Ni Sepharose (GE) column was pre-equilibrated with resuspension buffer before the supernatant was passed through. The protein was eluted off the column in elution buffer (20 mM HEPES, 200 mM NaCl, 500 mM imidazole, 1 mM TCEP, pH 7.4). Imidazole was removed by passing the protein solution through a HiTrap Desalting column (Sephadex G-25 Superfine, GE) pre-equilibrated in Desalting buffer (20 mM HEPES, 200 mM NaCl, 1 mM TCEP, pH 7.4). Removal of the His-GFP-TEV tag was facilitated by incubating the protein solution with 75 units of ProTEV Plus (5 U ml 21 , Promega) per 2 ml of protein solution overnight while gently rocking at 4 uC. ProTEV Plus and the cleaved His-GFP-TEV tag were removed by reverse-Ni IMAC chromatography. The column flow through was collected and flash frozen in liquid nitrogen before storage at 280 uC. The flow through was then checked via SDS-PAGE gel and Coomassie stain to determine the purity of RanGAP1. Electrophoretic mobility shift assays. A 24mer, 39mer or 60mer RNA (4 mM) containing the sequences (G 4 C 2 ), (C 4 G 2 ), or (CUG) with a 59 Cy5 label (IDT) was denatured at 95 uC for 5 min and then annealed in the presence or absence of 100 mM KCl in 10 mM Tris-HCl pH 7.4 to induce the respective formation of RNA G-quadruplexes or hairpins. The RNA was diluted to 2 nM in binding buffer (HEPES pH 7.5 with 100 mM KCl, 5 mM MgCl 2 , 50 mM ZnCl 2 , 1 mM TCEP, and 0.01% IGEPAL) and then incubated for 30 min at room temperature with varying concentrations of recombinant RanGAP1 (0, 1, 2, 10, 20, 50, 100 and 200 nM) in binding buffer. Samples were then loaded onto a 0.8% agarose gel in 13 TAE (pH 8.0) and electrophoresed for 45 min at 60 V. Bands were visualized using a Typhoon Image for Cy5 excitation and emissions. The image was analysed and quantified in ImageJ and then plotted in GraphPad prism. RanGAP1 binding was fit to a hyperbolic and linear regression, and based on the fit of the curve the k 1/2 calculated with B max set to 1 for nonlinear regression.
Competition experiments were performed by incubating a final concentration of 2 nM of RNA with 100 nM of RanGAP1 for 30 min at room temperature as above. Then unlabelled competitor, antisense oligonucleotide control, antisense oligonucleotide, RNaseH-dependent antisense oligonucleotide, or yeast tRNA was added to the sample at increasing concentrations, and allowed to incubate at room temperature for an additional 30 min. Samples were then analysed as above.
The effects of the porphyrin TMPyP4 on RanGAP1 binding to the RNA was performed essentially as above. RNA (2 nM) was incubated with varying concentrations of TMPyP4 that was serially diluted tenfold starting from a 1 mM final concentration in binding buffer. After 30 min incubation, 10 nM RanGAP1 was added and allowed to incubate for an additional 30 min; binding was analysed as described above. Protein extraction, protein/RNA pull down and immunoblot. Tissues or cells were homogenized and/or lysed in RIPA buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, and 1% Triton X-100) supplemented with protease inhibitor cocktail (Complete, Roche). For pull down, cells are lysed in lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% NP-40, and 5 mM MgCl 2 ) for 30 min on ice. The lysate was then pre-cleared using avidinagarose beads (Life Technologies) for 30 min before being incubated with biotinylated G 4 C 2 -repeat RNA with 10 mM TCEP and RNase inhibitor RNaseOUT (Life Technologies) 9 . Protein/RNA mixture was then incubated with avidinagarose beads overnight at 4 uC. The beads were subsequently precipitated by centrifuge at 1,500g for 3 min and washed three times in lysis buffer at 4 uC for a ARTICLE RESEARCH total time of 1 h. The beads were then resuspended in 50 ml lysis buffer and subjected to immunoblot analysis.
For immunoblot, the sample was mixed with Laemmli buffer and heated at 98 uC for 10 min. The protein samples were run on 4-15% SDS Mini-PROTEAN TGX Precast Gels (Bio-Rad) and transferred to nitrocellulose membrane. For dot blot, 2 ml of sample was blotted on nitrocellulose membrane and air-dried for 15 min. TBST with 5% milk was used for blocking. Primary antibodies were used as below: rat anti-HA (Roche), 1:1,000; chicken anti-GFP (abcam), 1:1,000; mouse anti-Actin (Millipore), 1:5,000; rabbit anti-GP (a gift from L. Petrucelli, Mayo Clinic), 1:1,000; and rabbit anti-GR (Proteintech), 1:1,000. The HRP-conjugated secondary antibody (Jackson ImmunoResearch) was used at 1:5,000 dilution. Drug feeding assay. Melt cornmeal-molasses-yeast fly food was mixed with certain concentrations of antisense oligonucleotide 573674 'CCGGCCCCGG CCCCGGCCCC' (Isis Pharmaceuticals), TMPyP4 (a porphyrin derivative) (Sigma), or KPT-276 (Selleckchem) at high temperature and cooled to RT. PBS was used as the vehicle control for antisense oligonucleotide and DMSO was used as the vehicle control for TMPyP4 and KPT-276. Parent flies were crossed on food supplemented with drugs and the offspring were raised on the same food. Wandering third instars of the offspring were selected and subjected to GFP staining. Antisense oligonucleotides were detected using the anti-antisense oligonucleotide (13545) antibody (Isis Pharmaceuticals), which detects the MOE modification. Adult flies were aged on the drug-containing food for 15 days before analysing their eye morphology. Statistics. No statistical methods were used to predetermine sample size. For quantification of outer eye morphological defects, ten flies were quantified. For quantifications of rhabdomere defects, 20 ommatidia from three or four flies were quantified for each genotype except RanGAP overexpression. For RanGAP overexpression, 24 ommatidia from four flies were quantified. For active zone quantifications, eight NMJs from four animals are quantified. For NMJ recording, the following numbers of animals were used for quantification: 18 for control, 10 for G 4 C 2 -expressing, 6 for RanGAP overexpression. For S2 cell quantifications, ten cells were quantified for each genotype. For image quantification of iPSC neurons, at least 31 neurons per line were quantified for all analyses and each cell line was differentiated and analysed at least two times at 55-70 DIV (as indicated) (see Supplementary Data Table 4 ). For qRT-PCR, six biological repeats, each containing three technical replicates in parallel, were used for quantification. For salivary gland quantifications, eight or nine salivary gland cells from three or four flies were quantified for each genotype. The numbers of flies used in the flight assay were labelled individually on the bar graph in Extended Data Fig. 1 . Error bars are presented as s.e.m. For analyses of data sets with two variables, we employed a two-tailed Student's t-test. For analyses of data sets with three or more variables, we employed a one-way ANOVA assuming Gaussian distribution with a Tukey's post hoc test for multiple comparisons. To assess correlation between N/C ratios, a correlation analysis with Pearson's coefficient was applied. To obtain r 2 values, a nonlinear regression curve fit assuming one-phase association was performed. A P value of , 0.05 was considered statistically significant for all tests (GraphPad Prism, Ver. 6.0b).
Extended Data Figure 6 | Electrophysiological and immunocytochemical characterization of iPSC neurons and astroglia. a, IR-DIC images of iPSC neurons from control (left panel) and C9orf72 (right panel) patient cells (a9). Representative action potentials in response to somatic current injections (70 pA) in iPSC neurons (b9-d9). The majority of cells from both groups displayed either single, adaptive or repetitive responses, as demonstrated previously 49 . These action potentials were blocked by TTX treatment. Normal (e9) and C9orf72 (f9) patient cells displayed mEPSCs that were sensitive to NBQX treatment, suggesting functional synaptic input. Resting membrane potential, membrane capacitance, and membrane resistance were comparable in both groups (g9-i9). b, Quantification of iPSC neuron markers showing glutamatergic and Islet-1 1 iPSC neurons. c, iPSCs differentiated into neurons include phenotypic markers such as Islet-1, HB9, ChAT (choline acetyl transferase, motor neuron); Tuj1, MAP2, SMI32 (cytoskeletal), VGLUT1 (vesicular glutamate transporter 1), NMDAR1 (NMDA receptor), and synaptic markers SYT1 (synaptotagmin) and SYP (synaptophysin). d, Astroglia markers include ALDH1 (universal astroglial marker) and GFAP (reactive astroglia).
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Extended Data Figure 7 | Additional human RanGAP1 and Nup107 pathology in C9-ALS brain. a, b, C9orf72 motor cortex (b) reveals aberrant nuclear localization of RanGAP1, compared to a non C9 control tissue (a), including various nuclear aggregate pathologies seen at higher power in C9orf72 ALS motor cortex (d) as compared to control (c). e, Aberrant RanGAP1 nuclear aggregates were not readily observed in C9-ALS cerebellar cortex molecular layer (ML), Purkinje cells (PK) or granule cell (GL) layer when compared to non C9-ALS control cerebellum. Number in the upper right of each panel identifies autopsy specimen (Supplementary  Table 2 ). f, Nup107 was also aggregated at the nuclear membrane in C9-ALS motor cortex cells when compared to non C9 control tissues. 1 neurons at 50-70 DIV. Number of C9-ALS iPSC neurons with RNA foci is reduced with C9orf72 RNA targeting antisense oligonucleotides compared to scrambled/non-targeting antisense oligonucleotides to ,10% of iPSC neurons. k, Antisense oligonucleotides that reduce G 4 C 2 RNA foci also enhance N/C Ran and N/C TDP-43 ratios. *P , 0.05; **P , 0.01; ****P , 0.0001.
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